Sun Pharma & Moebius Publish Phase 2b Data on MM-I...
Category : Clinical Trial Update 25 April 2025Sun Pharma and Israel-based Moebius Medical Limited announced the publication of two articles in ost...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Lupin Gets US FDA Approval for Tolvaptan Tablets f...
Category : Approval/Launch 25 April 2025Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United St...
Augurex’s SPINEstat Approved in UK for Axial Spond...
Category : Approval/Launch 25 April 2025Augurex Life Sciences, a leader in autoimmune biomarker-based diagnostics, announced that SPINEstat...
Doer Biologics Begins Phase 2 Dosing for DR10624 i...
Category : Clinical Trial Update 25 April 2025Zhejiang Doer Biologics Co., Ltd. (Doer Bio), a clinical stage biopharmaceutical company, announces...
Aclaris Gets FDA Nod to Begin Phase 1a/1b Trial of...
Category : Clinical Trial Update 24 April 2025Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel p...
Latest Newsletter Post
-
Doer Biologics Begins Phase 2 Dosin..
25 April 2025
-
Augurex’s SPINEstat Approved in UK..
25 April 2025
-
Lupin Gets US FDA Approval for Tolv..
25 April 2025
-
Sun Pharma & Moebius Publish Phase..
25 April 2025
-
Zealand Pharma Begins Phase 2b ZUPR..
24 April 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com